Target intelligence / Profile preview

Insulin-like growth factor 2 receptor (IGF2R)

Target
IGF2R
Molecular classification
Receptor, Type I transmembrane glycoprotein, P-type lectin
01

Overview

The insulin-like growth factor 2 receptor (IGF2R) IGF2-binding site, primarily located within domain 11 of the receptor's 15 extracellular repeats, is a highly specialized functional region responsible for binding and clearing extracellular insulin-like growth factor 2 (IGF2). By sequestering free IGF2 and directing it to lysosomes for degradation, this binding site acts as a natural tumor suppressor and negative regulator of cell growth. This clearance mechanism prevents excess IGF2 from activating mitogenic signaling through the IGF1 receptor (IGF1R) and insulin receptor isoform A (IR-A). In therapeutic development, this site is exploited in several ways. First, it is targeted by lysosome-targeting chimeras (LYTACs) that use engineered IGF2-based ligands to shuttle membrane-bound or extracellular oncoproteins to lysosomes for degradation. Second, it is utilized in enzyme replacement therapies (such as reveglucosidase alfa) that employ IGF2-derived peptide tags to enhance lysosomal delivery of therapeutic enzymes. Third, it is targeted by monoclonal antibodies (such as IF3) to deliver radionuclides to IGF2R-overexpressing tumors like osteosarcoma. However, targeting this site presents challenges, including the risk of hypoglycemia from off-target activation of IGF1R/insulin receptors by IGF2-based ligands. Additionally, target-mediated drug disposition, such as spleen accumulation, remains a concern due to the ubiquitous expression of IGF2R in normal tissues.

Other names
Insulin-like growth factor 2 receptor IGF2-binding siteIGF2R domain 11IGF2R repeat 11Cation-independent mannose-6-phosphate receptor domain 11CI-M6PR domain 11M6P/IGF2R domain 11IGF-II binding site of IGF2R
02

Mechanism of action

Bifunctional degradation (LYTAC-mediated endocytosis and lysosomal degradation of target proteins), receptor-mediated endocytosis and lysosomal delivery of therapeutic enzymes, sequestration of extracellular IGF2 (soluble receptor traps), and targeted radionuclide delivery (radioimmunotherapy)

03

Biological functions

Receptor-mediated endocytosisLysosomal traffickingProtein degradationRegulation of cell growthSequestration of insulin-like growth factor 2
04

Disease associations

CancerLysosomal storage diseaseMuscle diseaseNeurodegenerative disease
05

Safety considerations

Hypoglycemia (due to off-target activation of IGF1R or insulin receptors by IGF2-based ligands)Spleen toxicity / Spleen sink effect (due to target-mediated drug disposition in the spleen)Potential oncogenesis (if wild-type IGF2 is used, which can activate IGF1R)Immunogenicity of engineered proteins
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

IGF2R expression levelCirculating IGF2 levelsLysosomal glycogen accumulation

Beyond the preview

Go deeper on Insulin-like growth factor 2 receptor (IGF2R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulin-like growth factor 2 receptor (IGF2R).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call